Global Sales Of Depression Drugs Are Slated To Accelerate At A CAGR Of 4% To Top Us$ 20 Bn By 2031 | Fact.MR study
Depression Drugs Market Analysis By Drug Type (Generic Depression Drugs, Branded Depression Drugs), By Drug Class (Serotonin-norepinephrine Reuptake Inhibitors), By Disease (Major Depressive Disorder, Generalized …